应用皮质类固醇和来迪派韦-索磷布韦治疗丙型肝炎病毒感染相关的膜性肾病：一例报告并文献复习
Membranous nephropathy associated with hepatitis C virus infection treated with corticosteroids and Ledipasvir-Sofosbuvir: a case report and review of literature.
作者信息
Weng Qinjie, Li Xiao, Ren Hong, Xie Jingyuan, Pan Xiaoxia, Xu Jing, Chen Nan
机构信息
Department of Nephrology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
出版信息
Oncotarget. 2017 Mar 28;8(13):22299-22303. doi: 10.18632/oncotarget.15397.
BACKGROUND
Membranous nephropathy (MN) is the most common cause of nephrotic syndrome in adults. As many clinical cases have reported, it may be associated with hepatitis C virus (HCV) infection. Antiviral therapy can be various.
CASE SUMMARY
We report a case of patient with chronic HCV infection and MN, who presented with was proteinuria. He was treated with ledipasvir and sofosbuvir (Harvoni; Gilead Sciences, Foster City, CA) and was found to be virus-free.
CONCLUSION
We have reported this case to provide insight into whether Ledipasvir-Sofosbuvir should be administered for HCV-related glomerulonephritis.
背景
膜性肾病（MN）是成人肾病综合征最常见的病因。正如许多临床病例报道的那样，它可能与丙型肝炎病毒（HCV）感染有关。抗病毒治疗方法多种多样。
病例摘要
我们报告一例慢性HCV感染合并MN的患者，该患者表现为蛋白尿。他接受了来迪派韦和索磷布韦（Harvoni；吉利德科学公司，加利福尼亚州福斯特城）治疗，结果病毒检测呈阴性。
结论
我们报告此病例是为了深入了解是否应使用来迪派韦-索磷布韦治疗HCV相关性肾小球肾炎。
Zotero 插件